Location: Oslo, Norway
CIK: 0001475373 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 5, 2024
Total Value: $412M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MDT | MEDTRONIC PLC | 435,075 | $35.84M | 8.7% | $80.86 | -11.6% | SHS | G5960L103 |
| PFE | PFIZER INC | 1,093,416 | $31.48M | 7.6% | $26.40 | 0.0% | COM | 717081103 |
| GILD | GILEAD SCIENCES INC | 382,362 | $30.98M | 7.5% | $56.83 | +27.0% | COM | 375558103 |
| BIIB | BIOGEN INC | 102,234 | $26.46M | 6.4% | $271.36 | -9.5% | COM | 09062X103 |
| INCY | INCYTE CORP | 398,699 | $25.03M | 6.1% | $73.24 | -22.8% | COM | 45337C102 |
| BMY | BRISTOL-MYERS SQUIBB CO | 374,687 | $19.23M | 4.7% | $51.90 | -9.4% | COM | 110122108 |
| GEHC | GE HEALTHCARE TECHNOLOGIES I | 247,531 | $19.14M | 4.6% | $76.55 | -8.8% | COMMON STOCK | 36266G107 |
| CVS | CVS HEALTH CORP | 219,000 | $17.29M | 4.2% | $65.40 | 0.0% | COM | 126650100 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 141,218 | $17.19M | 4.2% | $115.60 | -5.4% | COM | 98956P102 |
| CAH | CARDINAL HEALTH INC | 164,305 | $16.56M | 4.0% | $50.01 | +91.4% | COM | 14149Y108 |
| CNC | CENTENE CORP DEL | 216,416 | $16.06M | 3.9% | $67.45 | +7.0% | COM | 15135B101 |
| THC | TENET HEALTHCARE CORP | 193,279 | $14.61M | 3.5% | $49.36 | +28.4% | COM NEW | 88033G407 |
| EW | EDWARDS LIFESCIENCES CORP | 187,556 | $14.3M | 3.5% | $79.03 | -12.0% | COM | 28176E108 |
| ELV | ELEVANCE HEALTH INC | 27,807 | $13.11M | 3.2% | $341.44 | +30.8% | COM | 036752103 |
| BAX | BAXTER INTL INC | 328,132 | $12.69M | 3.1% | $40.56 | -17.2% | COM | 071813109 |
| GMED | GLOBUS MED INC | 234,374 | $12.49M | 3.0% | $55.53 | -12.2% | CL A | 379577208 |
| — | LABORATORY CORP AMER HLDGS | 50,686 | $11.52M | 2.8% | $234.97 | — | COM NEW | 50540R409 |
| BRKR | BRUKER CORP | 127,312 | $9.355M | 2.3% | $54.62 | +16.3% | COM | 116794108 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 86,247 | $8.316M | 2.0% | $85.88 | +3.0% | COM | 09061G101 |
| — | QIAGEN NV | 190,539 | $8.275M | 2.0% | $46.62 | — | SHS NEW | N72482123 |
| BIO | BIO RAD LABS INC | 23,609 | $7.623M | 1.8% | $313.43 | 0.0% | CL A | 090572207 |
| IONS | IONIS PHARMACEUTICALS INC | 145,012 | $7.336M | 1.8% | $51.94 | -7.8% | COM | 462222100 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 32,092 | $6.143M | 1.5% | $201.08 | -15.3% | COM | 02043Q107 |
| ACAD | ACADIA PHARMACEUTICALS INC | 188,111 | $5.89M | 1.4% | $16.65 | +43.4% | COM | 004225108 |
| ILMN | ILLUMINA INC | 40,592 | $5.652M | 1.4% | $115.36 | 0.0% | COM | 452327109 |
| ALKS | ALKERMES PLC | 200,000 | $5.548M | 1.3% | $25.98 | 0.0% | SHS | G01767105 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 102,490 | $4.901M | 1.2% | $52.47 | -26.1% | COM | 90400D108 |
| ABT | ABBOTT LABS | 39,876 | $4.389M | 1.1% | $96.07 | 0.0% | COM | 002824100 |
| LNTH | LANTHEUS HLDGS INC | 52,316 | $3.244M | 0.8% | $88.96 | -23.8% | COM | 516544103 |
| VIR | VIR BIOTECHNOLOGY INC | 148,538 | $1.494M | 0.4% | $29.24 | -68.8% | COM | 92764N102 |